These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 21299475
1. Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. Woodruff PG, Albert RK, Bailey WC, Casaburi R, Connett JE, Cooper JA, Criner GJ, Curtis JL, Dransfield MT, Han MK, Harnden SM, Kim V, Marchetti N, Martinez FJ, McEvoy CE, Niewoehner DE, Reilly JJ, Rice K, Scanlon PD, Scharf SM, Sciurba FC, Washko GR, Lazarus SC, Copd Clinical Research Network. COPD; 2011 Feb; 8(1):21-9. PubMed ID: 21299475 [Abstract] [Full Text] [Related]
2. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. Liu MC, Dubé LM, Lancaster J. J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149 [Abstract] [Full Text] [Related]
12. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. Kane GC, Pollice M, Kim CJ, Cohn J, Dworski RT, Murray JJ, Sheller JR, Fish JE, Peters SP. J Allergy Clin Immunol; 1996 Feb 01; 97(2):646-54. PubMed ID: 8621850 [Abstract] [Full Text] [Related]
17. Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study. Nelson H, Kemp J, Berger W, Corren J, Casale T, Dube L, Walton-Bowen K, LaVallee N, Stepanians M. Ann Allergy Asthma Immunol; 2007 Aug 01; 99(2):178-84. PubMed ID: 17718106 [Abstract] [Full Text] [Related]
18. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers. Awni WM, Braeckman RA, Cavanaugh JH, Locke CS, Linnen PJ, Granneman GR, Dubé LM. Clin Pharmacokinet; 1995 Aug 01; 29 Suppl 2():112-24. PubMed ID: 8620667 [Abstract] [Full Text] [Related]
19. The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: a 6-month randomized controlled study. Wenzel S, Busse W, Calhoun W, Panettieri R, Peters-Golden M, Dube L, Walton-Bowen K, Russell H, Harris J. J Asthma; 2007 May 01; 44(4):305-10. PubMed ID: 17530530 [Abstract] [Full Text] [Related]